Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $24

Benzinga Newsdesk www.benzinga.com Neutral 64.5%

Neg 0% Neu 64.5% Pos 0%

Wedbush analyst Laura Chico maintains Alto Neuroscience (NYSE:ANRO) with a Neutral and raises the price target from $21 to $24.